SCHEMBL28032005

SCHEMBL28032005

COc1cc(OC)c(/C=C2\CC/C(=C\c3ccccc3C(F)(F)F)C2=O)c(OC)c1

nearest known ligand 0.65

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP24A1 Q07973 2/20 0.65
TNF P01375 3/20 0.65
IL6 P05231 3/20 0.65
GAA P10253 2/20 0.54
MEN1 O00255 1/20 0.54
ALDH1A1 P00352 1/20 0.54
KMT2A Q03164 1/20 0.54
EGFR P00533 4/20 0.52
XDH P47989 2/20 0.50
CYP26A1 O43174 2/20 0.50
NFE2L2 Q16236 5/20 0.46
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
ATM Q13315 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28031997 0.85 TNF (0.69) CYP24A1TNFIL6GAAMEN1
SCHEMBL28031993 0.85 TNF (0.69) CYP24A1TNFIL6GAAMEN1
SCHEMBL28031477 0.81 TNF (0.64) CYP24A1TNFIL6ALDH1A1KMT2A
SCHEMBL28031446 0.81 TNF (0.64) CYP24A1TNFIL6ALDH1A1KMT2A
SCHEMBL28005280 0.79 ALDH1A1 (0.54) GAAMEN1ALDH1A1KMT2AEGFR
SCHEMBL14119823 0.75 TNF (1.00) CYP24A1TNFIL6GAAMEN1
SCHEMBL14119825 0.75 TNF (1.00) CYP24A1TNFIL6GAAMEN1
SCHEMBL28032416 0.74 ALDH1A1 (0.56) CYP24A1TNFIL6GAAMEN1
SCHEMBL17077376 0.73 EGFR (0.90) GAAMEN1ALDH1A1KMT2AEGFR
SCHEMBL17077375 0.73 EGFR (0.90) GAAMEN1ALDH1A1KMT2AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104829440-A Single-side trifluoromethyl-substituted dibenzylalkenyl cyclopentanone capable of treating acute lung injury and like inflammatory diseases UNIV WENZHOU MEDICAL 2015-08-12 CN claimed